Compare OGN & EE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OGN | EE |
|---|---|---|
| Founded | 1923 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil/Gas Transmission |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.2B |
| IPO Year | 2020 | 2022 |
| Metric | OGN | EE |
|---|---|---|
| Price | $13.51 | $39.02 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 5 |
| Target Price | $11.40 | ★ $39.20 |
| AVG Volume (30 Days) | ★ 2.4M | 345.5K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | 0.60% | ★ 0.96% |
| EPS Growth | N/A | ★ 0.79 |
| EPS | ★ 0.55 | 0.37 |
| Revenue | ★ $6,216,000,000.00 | $1,228,263,000.00 |
| Revenue This Year | $0.45 | $23.59 |
| Revenue Next Year | $1.67 | $24.37 |
| P/E Ratio | ★ $24.59 | $105.57 |
| Revenue Growth | N/A | ★ 44.26 |
| 52 Week Low | $5.69 | $21.29 |
| 52 Week High | $13.60 | $43.18 |
| Indicator | OGN | EE |
|---|---|---|
| Relative Strength Index (RSI) | 62.13 | 61.18 |
| Support Level | $13.46 | $31.76 |
| Resistance Level | $13.60 | $39.86 |
| Average True Range (ATR) | 0.05 | 1.23 |
| MACD | -0.03 | -0.04 |
| Stochastic Oscillator | 35.71 | 59.87 |
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
Excelerate Energy Inc. offers comprehensive LNG solutions by providing integrated services throughout the LNG value chain. The company delivers a full range of regasification services, including Floating Storage and Regasification Units (FSRUs), infrastructure development, and the supply of LNG and natural gas. With operational presence in several countries - Argentina, Bangladesh, Brazil, Finland, Germany, Pakistan, the United Arab Emirates (UAE), and the United States. The company generates revenue through Terminal Services, as well as from LNG, gas, and power. These revenues are derived from its vertically integrated activities in LNG sourcing, transportation, regasification, and power generation.